Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
Topic
- Advertising (279)
- COVID-19 (163)
- Safety monitoring and information (104)
- Legislation (96)
- Compliance and enforcement (72)
- Manufacturing (57)
- Vaping hub (55)
- Labelling and packaging (38)
- Import and export (29)
- Scheduling (national classification system) (27)
- Medicinal cannabis hub (25)
- Sunscreens (18)
- Weight loss products (15)
- Shortages and supply disruptions (13)
- Committees and advisory bodies (9)
- Cosmetics (5)
- Unique Device Identification (UDI) hub (4)
- Clinical trials (3)
- Fees and payments (2)
- Prescription opioids hub (2)
- Urogynaecological (transvaginal) surgical mesh hub (2)
- Breast implant hub (1)
Search
1273 result(s) found, displaying 1076 to 1100
-
Media releasesImprovements to Consumer Medicine Information
-
Media releasesImportant information about the dangers of using thermography for breast cancer detection
-
News articlesChanges will be made to the regulation of nappy rash products on 1 January 2020
-
BlogIf you have any unwanted medicines, you can safely dispose of them at your local pharmacy.
-
Media releasesRisks associated with cosmetic injections can be related to both the product and the experience of the person performing the procedure
-
Media releasesThe Federal Court has imposed substantial penalties on Peptide Clinics Australia
-
Media releasesThe TGA has clarified that state and territory governments will continue to regulate fluoridated drinking water in Australia
-
-
Media releasesThe TGA is urging Australians to return unused prescription pain relief medicines to their local pharmacy
-
News articlesNew regulations for stem cell treatments in Australia came into force on 1 July 2019
-
Media releasesThe 2019 TGA stakeholder survey is open. Have your say before 5 July
-
Media releasesWe're encouraging all Australians to return their unused opioids to their local pharmacy
-
Media releasesInternational work-sharing initiative approves Niraparib (Zejula®)
-
News articlesThe transition period for updating medicine ingredient names ends on 30 April 2020.
-
BlogBee aware of the risks of natural medicines and medical devices.
-
Regulatory decision noticesThe Therapeutic Goods (Permissible Ingredients) Determination has been updated.
-
BlogOver the last few years we've updated the Australian names of some medicine ingredients to bring the names into line with the names used in other countries.
-
Media releasesReasons for releasing guidance and how it was developed
-
Media releasesOn Thursday 30 May 2019, the Therapeutic Goods Administration (TGA) executed four search warrants connected to a business operating in the Sutherland Shire, Sydney
-
Media releasesThe TGA has seized black salve products after executing a search warrant at a business premises on the Gold Coast
-
Media releasesCourt action continues against Peptide Clinics Australia for alleged advertising breaches
-
Media releasesTGA data analysis
-
BlogProvided all appropriate rules are followed, many medicines can be imported for personal use under the Personal Importation Scheme.
-
Safety updatesMedicines Safety Update article
-
BlogHeading overseas? Read our tips for travelling with medicines before you go